Cocaine and HIV Influence Mitochondrial Epigenetics in Astrocytic Networks

Information

  • Research Project
  • 9557476
  • ApplicationId
    9557476
  • Core Project Number
    R01DA044872
  • Full Project Number
    5R01DA044872-02
  • Serial Number
    044872
  • FOA Number
    PA-16-144
  • Sub Project Id
  • Project Start Date
    9/15/2017 - 8 years ago
  • Project End Date
    7/31/2022 - 3 years ago
  • Program Officer Name
    LOSSIE, AMY C
  • Budget Start Date
    8/1/2018 - 7 years ago
  • Budget End Date
    7/31/2019 - 6 years ago
  • Fiscal Year
    2018
  • Support Year
    02
  • Suffix
  • Award Notice Date
    7/16/2018 - 7 years ago
Organizations

Cocaine and HIV Influence Mitochondrial Epigenetics in Astrocytic Networks

Project Summary/Abstract Astrocytes are the major regulators for energy storage, utilization and metabolic function in the central nervous system (CNS). Cocaine abuse and HIV infections are significant risk factors for disrupting brain energy metabolism and cocaine abuse is strongly associated with HIV-1 infection and a subsequent development of AIDS. The proposed research is aimed at investigating the effects of cocaine and HIV-Transactivator protein (HIV-Tat) on astrocyte energy metabolism and associated neuronal impairments. Altered DNA methylation in the region of the mitochondrial genome encoding the NADH dehydrogenase (NDH- displacement loop (D-loop) Family) subunits (ND1-ND6) plays a critical role in energy storage and utilization by regulating the energy source of brain metabolism to preserve CNS cell functions. Therefore, we investigated the role of cocaine and/or HIV-1 infection on the mitochondrial epigenetic mechanisms that alters the astrocytic energy metabolism. Moreover, the role of mitochondrial DNA methyl transferases (mtDNMTs) in impacting energy deficits in astrocytes leading to neuronal impairment has never been elucidated in the context of either cocaine or HIV-Tat, or in combination. Our preliminary studies showed that cocaine and/or HIV-1 Tat targets DNMTs and mtDNMTs (mtDNMT1, mtDNMT3A and mtDNMT3B) with concomitant activation of mitochondrial biogenesis in peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1?) that is known to regulate mtDNA synthesis and control energy metabolism affecting neuro plasticity and spine density. We thus hypothesize that cocaine acts as a co-factor in the neuropathogenesis of HIV-Tat by activating DNMTs expression in astrocytes leading to energy deficits and impacting DNA methylation and mitochondrial biogenesis. These epigenetic mechanisms are mediated by of 5-methylcytosine (5-mC), 5-hydroxymethylcytosine (5hmC) the regulatory D-loop region and its effect and ten-eleven translocation (TET) family dioxygenases , which affect energy transfer into neurons and dysregulate neuro plasticity, spine density and cell growth. Accordingly, in the specific Aim # 1A we will examine whether cocaine in association with HIV-Tat affect energy dysfunction of astrocytes and impacts DNMTs, mtDNMTs and biogenesis-led energy transfer, in Aim 1B# we propose to determine the effect on neuroplasticity/ axons/ dendrites formation and cell growth in primary neurons thereby contributing to neuronal death; the specific Aim # 2, we will validate the mechanistic study involving cocaine exposure of HIV-Tat (GT-tg) transgenic mice to investigate the mtDNMTs role in energy metabolism, and whether piracetam (a neuro-protective agent) treatment reverses the effects of cocaine and HIV-Tat on mtDNMTs leading to neuro plasticity and axons/ dendrites formation to develop a therapeutic strategy regulating energy metabolism impacting neurotoxicity. An understanding of cocaine and HIV-associated astrocytes energy deficits that lead to neurotoxicity will have translational significance for therapeutic targeting and controlling the energy metabolism in HIV-infected cocaine users.

IC Name
NATIONAL INSTITUTE ON DRUG ABUSE
  • Activity
    R01
  • Administering IC
    DA
  • Application Type
    5
  • Direct Cost Amount
    318100
  • Indirect Cost Amount
    99475
  • Total Cost
    417575
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    279
  • Ed Inst. Type
  • Funding ICs
    NIDA:417575\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    NAED
  • Study Section Name
    NeuroAIDS and other End-Organ Diseases Study Section
  • Organization Name
    SETON HALL UNIVERSITY
  • Organization Department
  • Organization DUNS
    079324315
  • Organization City
    SOUTH ORANGE
  • Organization State
    NJ
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    070792646
  • Organization District
    UNITED STATES